Earnings Per Share (EPS) of $0.37, significantly surpassing the estimated $0.18.Revenue of approximately $228.9 million, exceeding the estimated $205.8 million.Low debt-to-equity ratio of 0.06 and a current ratio of 3.43, indicating strong financial health.Varex Imaging Corporation (NASDAQ:VREX), a key player in the medical products industry, specializes in imaging components crucial for medical diagnostics. Competing in the medical imaging sector, Varex strives to deliver innovative solutions and has recen ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

For the quarter ended September 2025, VAREX IMAGING (VREX) reported revenue of $228.9 million, up 11.3% over the same period last year. EPS came in at $0.37, compared to $0.19 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $220.45 million, representing a surprise of +3.83%. The company delivered an EPS surprise of +105.56%, with the consensus EPS estimate being $0.18.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- ...

季度业绩表现 - 季度每股收益为0.37美元，远超市场预期的0.18美元，同比去年0.19美元增长94.7% [1] - 本季度收益超出预期105.56%，上一季度实际收益0.18美元亦远超预期的0.04美元，超出幅度达350% [1] - 季度营收为2.289亿美元，超出市场预期3.83%，同比去年2.057亿美元增长11.3% [2] - 在过去四个季度中，公司四次超出每股收益预期，三次超出营收预期 [2] 股价表现与市场比较 - 公司股价年初至今下跌约21.7%，而同期标普500指数上涨13.4% [3] - 公司所属的医疗产品行业在Zacks行业排名中处于后30%位置 [8] 未来业绩预期与评级 - 当前市场对下一季度的共识预期为每股收益0.21美元，营收2.0765亿美元 [7] - 当前财年共识预期为每股收益0.97美元，营收8.6155亿美元 [7] - 公司当前Zacks评级为第3级（持有），预计近期表现将与市场同步 [6] 同行业公司比较 - 同行业公司OrganiGram预计在截至2025年9月的季度报告每股亏损0.01美元，同比改善75% [9] - OrganiGram预计季度营收为5314万美元，同比大幅增长62.2% [9]

Varex Imaging (NasdaqGS:VREX) Q4 2025 Earnings Call November 18, 2025 05:00 PM ET Company ParticipantsSam Maheshwari - CFOSunny Sanyal - President and CEOChris Belfiore - Director of Investor RelationsConference Call ParticipantsLarry Solow - Managing Director and Healthcare AnalystJim Sidoti - Research Analyst of Medical DevicesAnderson Schock - MedTech Equity Research AnalystSuraj Kalia - Managing Director and Senior Analyst of Medical Technology and DevicesOperatorGreetings and welcome to the Varex Fourt ...

Varex Imaging (NasdaqGS:VREX) Q4 2025 Earnings Call November 18, 2025 05:00 PM ET Company ParticipantsSam Maheshwari - CFOSunny Sanyal - President and CEOChris Belfiore - Director of Investor RelationsConference Call ParticipantsLarry Solow - Managing Director and Healthcare AnalystJim Sidoti - Research Analyst of Medical DevicesAnderson Schock - MedTech Equity Research AnalystSuraj Kalia - Managing Director and Senior Analyst of Medical Technology and DevicesOperatorGreetings and welcome to the Varex Fourt ...

Varex Imaging (NasdaqGS:VREX) Q4 2025 Earnings Call November 18, 2025 05:00 PM ET Speaker5Greetings and welcome to the Varex Fourth Quarter Fiscal Year 2025 Earnings Conference Call and Webcast. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. You may be placed into question queue at any time by pressing Star 1 on your telephone keypad. If anyone should require operator assistance, please press Star 0. As a reminder, this conference ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

11/18/2025 1 Making the Invisible Visible Q4 FY25 Earnings Presentation November 18, 2025 While forward-looking statements are based on assumptions and analyses made by management of Varex that it believes to be reasonable under the circumstances, whether actual results and developments will meet such expectations depends on a number of risks and uncertainties which could cause actual results, performance, and financial condition to differ materially from such expectations. Such risks and uncertainties incl ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...